Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — the earnings record

Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.

The record at a glance

Reactions across the covered prints span -9.4% to +13.5% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $0.23 · est revenue ~$0.81B into the next print.

Print by print

Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for AMRX yet.